| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Thomas W. Ross Sr. is Director at BHC, with reported holdings spanning 2 companies. Thomas W. Ross Sr.'s net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.0M at current prices.
Thomas W. Ross Sr.'s largest disclosed position is in BLCO as Director, worth about $1.7M. Net of sales, the BLCO filings show accumulation of 4,500 shares.
Thomas W. Ross Sr. has 18 Form 4 filings on record from March 2016 to May 2026, across 2 companies: Director at Bausch + Lomb (BLCO), 2022–2026; Director at Bausch Health Companies (BHC), 2016–2023.
The 19 reported transactions were 15 stock awards and 4 open-market purchases.
Counted by filing, the open-market trades come to 4 purchases worth about $290K and no sales.
The largest open-market purchase was 4,000 shares of BHC at an average $24.40 on June 13, 2016, about $98K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | BLCO Bausch + Lomb Corporation | Director | Buy | 4,500 | $17.68 | $79,555.50 | +7.5% | -14.4% | - | |
| Mar 12, 2020 | BHC Bausch Health Companies Inc. | Director | Buy | 2,500 | $15.54 | $38,837.50 | +3.3% | - | - | |
| Dec 14, 2016 | BHC Bausch Health Companies Inc. | Director | Buy | 5,000 | $14.73 | $73,650.00 | +22.9% | - | - | |
| Jun 13, 2016 | BHC Bausch Health Companies Inc. | Director | Buy | 4,000 | $24.40 | $97,600.00 | +22.4% | - | - |